TY - UNPB
T1 - Clinical and epidemiological characteristics among probable and confirmed patients with mpox in Sierra Leone reported from January to May 2025
AU - Kangbai, Jia B
AU - Saidu, Emmanuel
AU - Foday, Ibrahim K
AU - Kamanda, Emmanuel S
AU - Jaba, Michaella
AU - Campbell, Allan
AU - Tia, Alie Brima
AU - Ruis, Christopher M
AU - Subissi, Lorenzo
AU - Halbrook, Megan
AU - Merritt, Sydney
AU - Hoff, Nicole A
AU - Kinganda-Lusamaki, Eddy
AU - Liesenborghs, Laurens
AU - Bogoch, Isaac I
AU - Shaw, Souradet Y
AU - Mbala-Kingebeni, Placide
AU - Rimoin, Anne W
AU - Kindrachuk, Jason
N1 - FTX: CC BY ND
PY - 2025/6/9
Y1 - 2025/6/9
N2 - We analyzed available mpox cases reports in Sierra Leone from January to June 2025 following a historic increase in mpox cases across multiple urban and rural regions in the country. Here, we assessed demographic and clinical data from 187 case reports. Mpox case reports in this study were primarily from Bo (86/187; 46.0%) and Freetown (48/124; 25.7%). Most case reports were from male patients (101/187; 54.0%) as compared to females (86/187; 46.0%), with an overall median age of 26 years (IQR 22-34). The median age was higher among males (30 years; IQR 25-39) then females (24 years; IQR 21-27). Rash, fever, headache, lesions, and generalized pain were reported for all patients, where data was reported. Lymphadenopathy, muscle pain, sore throat, and cough were reported less commonly. Age- and sex-specific interventions, as well as community engagement that includes historically stigmatized groups are critical for mpox containment and mitigation measures in Sierra Leone.
AB - We analyzed available mpox cases reports in Sierra Leone from January to June 2025 following a historic increase in mpox cases across multiple urban and rural regions in the country. Here, we assessed demographic and clinical data from 187 case reports. Mpox case reports in this study were primarily from Bo (86/187; 46.0%) and Freetown (48/124; 25.7%). Most case reports were from male patients (101/187; 54.0%) as compared to females (86/187; 46.0%), with an overall median age of 26 years (IQR 22-34). The median age was higher among males (30 years; IQR 25-39) then females (24 years; IQR 21-27). Rash, fever, headache, lesions, and generalized pain were reported for all patients, where data was reported. Lymphadenopathy, muscle pain, sore throat, and cough were reported less commonly. Age- and sex-specific interventions, as well as community engagement that includes historically stigmatized groups are critical for mpox containment and mitigation measures in Sierra Leone.
U2 - 10.1101/2025.05.30.25328691
DO - 10.1101/2025.05.30.25328691
M3 - Preprint
C2 - 40585101
T3 - medRxiv : the preprint server for health sciences
BT - Clinical and epidemiological characteristics among probable and confirmed patients with mpox in Sierra Leone reported from January to May 2025
PB - medRxiv
ER -